Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia
- PMID: 17961228
- PMCID: PMC2216027
- DOI: 10.1186/1471-2334-7-122
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia
Abstract
Background: IFN-gamma Release Assays (IGRAs) have been licensed for the diagnosis of latent Mycobacterium tuberculosis infection (LTBI). Their performance may depend on assay format and may vary across populations and settings. We compared the diagnostic performance of an in-house T -cell and commercial whole blood-based IGRAs for the diagnosis of LTBI and TB disease in The Gambia.
Methods: Newly diagnosed sputum smear positive cases and their household contacts were recruited. Cases and contacts were bled for IGRA and contacts had a Mantoux skin test. We assessed agreement and discordance between the tests and categorized a contact's level of M. tuberculosis exposure according to where s/he slept relative to a case: the same room, same house or a different house. We assessed the relationship between exposure and test results by multiple logistic regression.
Results: In 80 newly diagnosed TB cases, the sensitivity of ELISPOT was 78.7% and for QFT-GIT was 64.0% (p = 0.047). Of 194 household contacts 57.1% and 58.8% were positive for ELISPOT and QFT-GIT respectively. The overall agreement between both IGRAs for LTBI in contacts was 71.4% and there was no significant discordance (p = 0.29). There was significant discordance between the IGRAs and TST. Neither IGRA nor TST had evidence of false positive results because of Bacille Calmette Guérin (BCG) vaccination. However, agreement between QFT-GIT and TST as well as discordance between both IGRAs and TST were associated with BCG vaccination. Both IGRAs responded to the M. tuberculosis exposure gradient and were positively associated with increasing TST induration (p = 0.003 for ELISPOT and p = 0.001 for QFT-GIT).
Conclusion: The ELISPOT test is more sensitive than the QFT-GIT for diagnosing TB disease. The two tests perform similarly in the diagnosis of LTBI in TB contacts. Significant discordance between the two IGRAs and between each and the TST remain largely unexplained.
Figures
Similar articles
-
Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia.Pediatr Infect Dis J. 2010 May;29(5):439-43. doi: 10.1097/INF.0b013e3181cb45da. Pediatr Infect Dis J. 2010. PMID: 20068506
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
-
Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.Clin Vaccine Immunol. 2007 Jul;14(7):880-5. doi: 10.1128/CVI.00132-07. Epub 2007 May 16. Clin Vaccine Immunol. 2007. PMID: 17507543 Free PMC article. Clinical Trial.
-
Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.J Microbiol Immunol Infect. 2016 Oct;49(5):729-736. doi: 10.1016/j.jmii.2014.08.010. Epub 2014 Nov 1. J Microbiol Immunol Infect. 2016. PMID: 25442858
-
Interferon gamma release assays: principles and practice.Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52. doi: 10.1016/j.eimc.2009.05.012. Epub 2009 Sep 24. Enferm Infecc Microbiol Clin. 2010. PMID: 19783328 Review.
Cited by
-
Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection.BMC Infect Dis. 2010 Mar 20;10:75. doi: 10.1186/1471-2334-10-75. BMC Infect Dis. 2010. PMID: 20302657 Free PMC article.
-
A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.Korean J Intern Med. 2016 May;31(3):517-24. doi: 10.3904/kjim.2015.095. Epub 2016 Apr 7. Korean J Intern Med. 2016. PMID: 27052266 Free PMC article. Clinical Trial.
-
Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.PLoS One. 2014 May 12;9(5):e96564. doi: 10.1371/journal.pone.0096564. eCollection 2014. PLoS One. 2014. PMID: 24819060 Free PMC article.
-
Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area.BMC Infect Dis. 2009 Jul 3;9:105. doi: 10.1186/1471-2334-9-105. BMC Infect Dis. 2009. PMID: 19575781 Free PMC article.
-
Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.PLoS One. 2017 Nov 28;12(11):e0188631. doi: 10.1371/journal.pone.0188631. eCollection 2017. PLoS One. 2017. PMID: 29182688 Free PMC article.
References
-
- WHO Tuberculosis. Fact Sheet No 104, Accessed April 10, 2007. 2007. http://www.who.int/mediacentre/factsheets/fs104/en/
-
- Pitman R, Jarman B, Coker R. Tuberculosis transmission and the impact of intervention on the incidence of infection. Int J Tuberc Lung Dis. 2002;6:485–491. - PubMed
-
- Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002;359:1393–1401. doi: 10.1016/S0140-6736(02)08353-8. - DOI - PubMed
-
- Huebner RE, Schein MF, Bass JB., Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968–975. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources